no statement of use filed
on 09 Oct 2023
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
90382655 filed on 15th Dec 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, geneticRead More
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
No 90382655
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
10th Oct 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
09th Oct 2023 | ABANDONMENT - NO USE STATEMENT FILED |
21st Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
17th Feb 2023 | SOU TEAS EXTENSION RECEIVED |
17th Feb 2023 | SOU EXTENSION 3 FILED |
17th Feb 2023 | SOU EXTENSION 3 GRANTED |
08th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
06th Sep 2022 | SOU TEAS EXTENSION RECEIVED |
06th Sep 2022 | SOU EXTENSION 2 FILED |
06th Sep 2022 | SOU EXTENSION 2 GRANTED |